Does Dilantin (phenytoin) cause side effects?
Dilantin (phenytoin) is an anti-seizure medication (anticonvulsant) used to prevent or treat generalized tonic-clonic (grand mal) seizures, complex partial seizures (psychomotor seizures), and seizures occurring during or after neurosurgery. It may be used alone or with phenobarbital or other anticonvulsants.
Common side effects of Dilantin include
- difficulty focusing (vision),
- unsteady gate,
- abnormal involuntary movements,
- abdominal pain, and
- loss of appetite.
Less common side effects of Dilantin include
- overgrowth of the gums (in children and young adults during long-term therapy),
- sexual dysfunction (such as decreased libido, impotence, and painful, prolonged erections),
- darkened skin coloration (more commonly in women), and
- unusual hair growth that may be irreversible.
Serious side effects of Dilantin include
- severe rashes,
- lymph node reactions,
- increased blood sugar levels,
- liver injury,
- decreased platelet or white blood cell counts,
- weakening of the bones (osteomalacia), and
- an increased risk of suicidal thinking and behavior.
- oral contraceptives,
- valproic acid, and
Drugs that increase Dilantin blood levels and toxicity include
- acute alcohol intake,
- tolbutamide, and
Drugs that may decrease Dilantin levels and reduce effectiveness include
The oral absorption of Dilantin can be reduced by antacids containing magnesium, calcium carbonate, or aluminum; calcium salts; or enteral feeding products (tube feedings).
There is an increased risk of malformations and birth defects in women taking Dilantin. Dilantin should be used in pregnancy only if the physician feels that the potential benefit outweighs the risk. Dilantin is secreted into breast milk. Breastfeeding is not recommended while taking Dilantin.
What are the important side effects of Dilantin (phenytoin)?
Many adverse effects can occur during phenytoin therapy including:
- difficulty focusing (vision),
- unsteady gate,
- abnormal involuntary movements,
- abdominal pain, and
- loss of appetite.
Children and young adults can develop overgrowth of the gums during long-term therapy which requires regular treatment by a dentist. Good oral hygiene and gum massage may reduce the risk.
Rashes can occur in between 1 in 20 and 1 in 10 persons; some may be severe. Additionally, darkening coloration of the skin may develop (more commonly in women). Phenytoin can produce unusual growth of hair in some patients. This reaction most commonly affects the arms and legs but can also affect the trunk and face; it may be irreversible.
Various lymph node reactions have been reported with phenytoin therapy. Lymph nodes may swell, sometimes painfully.
Phenytoin can potentially injure the liver although this is an uncommon occurrence.
Phenytoin can cause the platelet or white blood cell counts to drop, increasing the risk of bleeding or infection, respectively. Phenytoin also can cause anemia.
Because it interferes with vitamin D metabolism, phenytoin can cause weakening of the bones (osteomalacia).
Other important side effects caused by phenytoin include sexual dysfunction, such as:
Antiepileptic medications have been associated with an increased risk of suicidal thinking and behavior. Anyone considering the use of antiepileptic drugs must balance this risk of suicide with the clinical need for the antiepileptic drug.
Patients who begin antiepileptic therapy should be closely observed for clinical worsening, suicidal thoughts or unusual changes in behavior.
Dilantin (phenytoin) side effects list for healthcare professionals
The following serious adverse reactions are described elsewhere in the labeling:
- Cardiovascular Risk Associated with Rapid Infusion
- Withdrawal Precipitated Seizure, Status Epilepticus
- Serious Dermatologic Reactions
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity
- Hepatic Injury
- Hematopoietic Complications
- Local toxicity (Including Purple Glove Syndrome)
- Exacerbation of Porphyria
- Teratogenicity and Other Harm to the Newborn
The following adverse reactions associated with the use of Dilantin were identified in clinical studies or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
The most notable signs of toxicity associated with the intravenous use of this drug are cardiovascular collapse and/or CNS depression. Hypotension does occur when the drug is administered rapidly by the intravenous route. The rate of administration is very important; it should not exceed 50 mg per minute in adults, and 1 to 3 mg/kg/min (or 50 mg per minute, whichever is slower) in pediatric patients.
Body As A Whole
There have also been reports of coarsening of facial features, systemic lupus erythematosus, periarteritis nodosa, and immunoglobulin abnormalities.
Severe cardiovascular events and fatalities have been reported with atrial and ventricular conduction depression and ventricular fibrillation. Severe complications are most commonly encountered in elderly or critically ill patients.
Hematologic And Lymphatic System
Hematopoietic complications, some fatal, have occasionally been reported in association with administration of phenytoin. These have included thrombocytopenia, leukopenia, granulocytopenia, agranulocytosis, and pancytopenia with or without bone marrow suppression. While macrocytosis and megaloblastic anemia have occurred, these conditions usually respond to folic acid therapy. Lymphadenopathy, including benign lymph node hyperplasia, pseudolymphoma, lymphoma, and Hodgkin's Disease have been reported.
Laboratory Test Abnormality
Phenytoin may decrease serum concentrations of thyroid hormone (T4 and T3), sometimes with an accompanying increase in thyroid-stimulating hormone (TSH), but usually in the absence of clinical hypothyroidism. Phenytoin may also produce lower than normal values for dexamethasone or metyrapone tests. Phenytoin may also cause increased serum levels of glucose, alkaline phosphatase, and gamma glutamyl transpeptidase (GGT).
The most common adverse reactions encountered with phenytoin therapy are nervous system reactions and are usually dose-related. Reactions include nystagmus, ataxia, slurred speech, decreased coordination, somnolence, and mental confusion. Dizziness, vertigo, insomnia, transient nervousness, motor twitchings, paresthesia, and headaches have also been observed. There have also been rare reports of phenytoin induced dyskinesias, including chorea, dystonia, tremor and asterixis, similar to those induced by phenothiazine and other neuroleptic drugs. Cerebellar atrophy has been reported, and appears more likely in settings of elevated phenytoin levels and/or long-term phenytoin use.
A predominantly sensory peripheral polyneuropathy has been observed in patients receiving long-term phenytoin therapy.
Skin And Appendages
Dermatological manifestations sometimes accompanied by fever have included scarlatiniform or morbilliform rashes. A morbilliform rash (measles-like) is the most common; other types of dermatitis are seen more rarely. Other more serious forms which may be fatal have included bullous, exfoliative or purpuric dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. There have also been reports of hypertrichosis.
Local irritation, inflammation, tenderness, necrosis, and sloughing have been reported with or without extravasation of intravenous phenytoin.
Altered taste sensation including metallic taste.
What drugs interact with Dilantin (phenytoin)?
Phenytoin is extensively bound to plasma proteins and is prone to competitive displacement. Phenytoin is metabolized by hepatic cytochrome P450 enzymes CYP2C9 and CYP2C19 and is particularly susceptible to inhibitory drug interactions because it is subject to saturable metabolism. Inhibition of metabolism may produce significant increases in circulating phenytoin concentrations and enhance the risk of drug toxicity. Monitoring of phenytoin serum levels is recommended when a drug interaction is suspected.
Phenytoin is a potent inducer of hepatic drug-metabolizing enzymes.
Drugs That Affect Phenytoin Concentrations
Table 1 includes commonly occurring drug interactions that affect phenytoin concentrations. However, this list is not intended to be inclusive or comprehensive. Individual prescribing information from relevant drugs should be consulted.
The addition or withdrawal of these agents in patients on phenytoin therapy may require an adjustment of the phenytoin dose to achieve optimal clinical outcome.
Table 1: Drugs That Affect Phenytoin Concentrations
|Drugs that may increase phenytoin serum levels|
|Antiepileptic drugs||Ethosuximide, felbamate, oxcarbazepine, methsuximide, topiramate|
|Azoles||Fluconazole, ketoconazole, itraconazole, miconazole, voriconazole|
|Antineoplastic agents||Capecitabine, fluorouracil|
|Antidepressants||Fluoxetine, fluvoxamine, sertraline|
|Gastric acid reducing agents||H2 antagonists (cimetidine), omeprazole|
|Sulfonamides||Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim|
|Other||Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin|
|Drugs that may decrease phenytoin serum levels|
|Antineoplastic agents usually in combination||Bleomycin, carboplatin, cisplatin, doxorubicin, methotrexate|
|Antiviral agents||Fosamprenavir, nelfinavir, ritonavir|
|Antiepileptic drugs||Carbamazepine, vigabatrin|
|Other||Chronic alcohol abuse, diazepam, diazoxide, folic acid, reserpine, rifampin, St. John’s wortb, theophylline|
|Drugs that may either increase or decrease phenytoin serum levels|
|Antiepileptic drugs||Phenobarbital, valproate sodium, valproic acid|
|b The induction potency of St. John's wort may vary widely based on preparation.|
Drugs Affected By Phenytoin
Table 2 includes commonly occurring drug interactions affected by phenytoin. However, this list is not intended to be inclusive or comprehensive. Individual drug package inserts should be consulted. The addition or withdrawal of phenytoin during concomitant therapy with these agents may require adjustment of the dose of these agents to achieve optimal clinical outcome.
Table 2: Drugs Affected by Phenytoin
|Drugs whose efficacy is impaired by phenytoin|
|Azoles||Fluconazole, ketoconazole, itraconazole, posaconazole, voriconazole|
|Antineoplastic agents||Irinotecan, paclitaxel, teniposide|
|Delavirdine||Phenytoin can substantially reduce the concentrations of delavirdine. This can lead to loss of virologic response and possible resistance.|
|Neuromuscular blocking agents||Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. Whether or not phenytoin has the same effect on other non-depolarizing agents is unknown.
Prevention or Management:
Patients should be monitored closely for more rapid recovery from neuromuscular blockade than expected, and infusion rate requirements may be higher.
|Warfarin||Increased and decreased PT/INR responses have been reported when phenytoin is coadministered with warfarin|
|Other||Corticosteroids, doxycycline, estrogens, furosemide, oral contraceptives, paroxetine, quinidine, rifampin, sertraline, theophylline, and vitamin D|
|Drugs whose level is decreased by phenytoin|
|Antiepileptic drugsa||Carbamazepine, felbamate, lamotrigine, topiramate, oxcarbazepine,|
|Antilipidemic agents||Atorvastatin, fluvastatin, simvastatin|
|Antiviral agents||Efavirenz, lopinavir/ritonavir, indinavir, nelfinavir, ritonavir, saquinavir Fosamprenavir: phenytoin when given with fosamprenavir alone may decrease the concentration of amprenavir, the active metabolite. Phenytoin when given with the combination of fosamprenavir and ritonavir may increase the concentration of amprenavir|
|Calcium channel blockers||Nifedipine, nimodipine, nisoldipine, verapamil|
|Other||Albendazole (decreases active metabolite), chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine|
|a The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels is unpredictable|
Drug/Laboratory Test Interactions
Care should be taken when using immunoanalytical methods to measure serum phenytoin concentrations following fosphenytoin administration.
Dilantin (phenytoin) is an anti-seizure medication (anticonvulsant) used to prevent or treat generalized tonic-clonic (grand mal) seizures, complex partial seizures (psychomotor seizures), and seizures occurring during or after neurosurgery. It may be used alone or with phenobarbital or other anticonvulsants. Common side effects of Dilantin include dizziness, drowsiness, difficulty focusing (vision), unsteady gate, tiredness, abnormal involuntary movements, nausea, vomiting, constipation, abdominal pain, and loss of appetite. There is an increased risk of malformations and birth defects in women taking Dilantin. Breastfeeding is not recommended while taking Dilantin.
Multimedia: Slideshows, Images & Quizzes
What Is Epilepsy? Symptoms, Causes, and Treatments
Learn about epilepsy symptoms and treatment for this seizure condition. Discover the definition of epilepsy, how epilepsy is...
Epilepsy & Seizures Quiz: What Causes Seizures?
Do you know the difference between seizures and epilepsy? What are the types of seizures? Take the Epilepsy & Seizures Quiz to...
Related Disease Conditions
Types of Traumatic Brain Injury (TBI) Medications
Traumatic brain injury and related conditions, may require diuretics, anticonvulsants, sedatives, antidepressants, muscle relaxers, pain relievers, and stimulants to treat deficits in cognitive functions such as attention, memory, learning and language.
Migraines and Seizures
Migraines are a type of headache and seizures are the main symptom of epilepsy. Migraine headaches and seizures are two different neurological problems that have similar signs, symptoms, and auras, for example, sensitivity to light (photophobia) and sound, irritability, nausea, and vomiting. Symptoms unique to migraine and migraine auras are water retention, problems sleeping, appetite changes, and talkativeness. Symptoms unique to seizure and seizures auras are depression, a feeling of heaviness, a feeling that a seizure is approaching, and depression. Many of the symptoms of migraine and seizures are the same, however, seizures do not cause migraines; however, people who have seizures are twice as likely to have migraines and vice-versa. People who have migraines are twice as likely to have seizures, and people with seizures are twice as likely to have migraines; however, one condition does not cause the other.
Seizures: Symptoms and Types
Seizures occur when there is an abnormal burst of electrical activity in the brain and are divided into two categories: generalized and partial. Learn about the symptoms of different types of seizures, and check out the center below for more medical references on seizures, including multimedia (slideshows, images, and quizzes), related diseases, treatment, diagnosis, medications, and prevention or wellness.
Febrile seizures, or convulsions caused by fever, can be frightening in small children or infants. However, in general, febrile seizures are harmless. Febrile seizure is not epilepsy. It is estimated that one in every 25 children will have at least one febrile seizure. It is important to know what to do to help your child if he/she has a febrile seizure. Some of the features of a febrile seizure include losing consciousness, shaking, moving limbs on both sides of the body, and lasts 1-2 minutes. Less commonly, a febrile seizure may only affect one side of the body.
Seizure vs. Seizure Disorders: What's the Difference?
Seizures and seizure disorders are not the same medical problems. A seizure happens when the electrical activity in the brain is uncontrolled. There are about 40 different types of seizure disorders, in which epilepsy is one. Symptoms depend on the type of disorder, but can include loss of consciousness, uncontrolled twitching or shaking of one side, or the entire body.
What Is the Best Treatment for Whooping Cough?
Learn what medical treatments can help ease your whooping cough symptoms and speed up your recovery.
Treatment & Diagnosis
- Epilepsy and Seizures FAQs
- What Are the Different Types of Epilepsy?
- Why Remove Half A Brain?
- Seizure Symptoms: How to Assist the Victim
- Seizures: When the Computer Goes Haywire
- Senator Ted Kennedy: Seizure, Brain Cancer, and Death
- Brain Cancer Symptoms: Headaches and Seizures
- Does Lupus Cause Seizures?
- What Is a Jacksonian Seizure?
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.